1. Home
  2. DSP vs STXS Comparison

DSP vs STXS Comparison

Compare DSP & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viant Technology Inc.

DSP

Viant Technology Inc.

HOLD

Current Price

$12.17

Market Cap

213.3M

Sector

Technology

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.79

Market Cap

190.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSP
STXS
Founded
1999
1990
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.3M
190.6M
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
DSP
STXS
Price
$12.17
$1.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
2
Target Price
$17.81
$4.00
AVG Volume (30 Days)
297.1K
386.6K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
157.14
16.67
EPS
N/A
N/A
Revenue
$344,201,000.00
$29,346,617.00
Revenue This Year
$20.27
$28.22
Revenue Next Year
$16.88
$30.47
P/E Ratio
N/A
N/A
Revenue Growth
19.00
N/A
52 Week Low
$8.11
$1.70
52 Week High
$15.18
$3.59

Technical Indicators

Market Signals
Indicator
DSP
STXS
Relative Strength Index (RSI) 53.46 41.79
Support Level $10.86 $1.73
Resistance Level $12.61 $1.99
Average True Range (ATR) 0.88 0.10
MACD 0.13 -0.01
Stochastic Oscillator 47.03 20.00

Price Performance

Historical Comparison
DSP
STXS

About DSP Viant Technology Inc.

Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: